Policy positions
Policy position 1
When assessing the value of innovative treatments, procedures or services in healthcare, we should focus on a cost-effectiveness analysis by asking: how many quality-adjusted life years will be saved with this innovation, and what are the direct medical costs of the innovation, compared to the best available alternative?
Policy position 2
When assessing the value of innovative treatments, procedures or services in healthcare, we should focus on a cost-effectiveness analysis as in policy position 1, and also ask: what impact will this innovation have on the costs of social care, unemployment, housing and disability benefits?
Policy position 3
When assessing the value of innovative treatments, procedures or services in healthcare, we should focus on a cost-effectiveness analysis which also looks at the impact of non-medical costs as in policy position 2, and also ask: what effects does this innovation have on the quality of life of informal caregivers and healthcare professionals?
Policy position 4
When assessing the value of innovative treatments, procedures or services in healthcare, we should focus on a cost-effectiveness analysis which looks at non-medical costs, quality of life of caregivers and healthcare professionals as in as in policy position 3, and also ask: what is the impact of this innovation on workplace productivity, jobs and the economy?